CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Truist Adjusts Price Target on Edwards Lifesciences to $95 From $90, Maintains Hold Rating

Neutral
AI Analysis

Summary

Truist raised its price target on Edwards Lifesciences to $95 from $90 while maintaining a Hold rating on the stock.

Importance:2/10
Sentiment:
0.00
price_target_adjustmentanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 16, 2026 1:14 PM

Read Original